Robin Sherrington (CIK 0001619962)

Latest company ownership

XENE - Xenon Pharmaceuticals Inc.

Role: EVP, Strategy & Innovation

Shares held

7,407

Last filed at

Mar 8, 2024

Confidence Score

50.0

2025Q4

Confidence Score History

2015Q3 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Mar 7, 2024	Mar 8, 2024	Xenon Pharmaceuticals Inc.	EVP, Strategy & Innovation	Sell	20.0	-8,641	-15.29%	✗	$399.4K
Aug 31, 2022	Sep 2, 2022	Xenon Pharmaceuticals Inc.	EVP, Strategy & Innovation	Sell	17.5	-72,924	-31.58%	✗	$2.8M
Mar 4, 2022	Mar 8, 2022	Xenon Pharmaceuticals Inc.	EVP, Strategy & Innovation	Sell	20.0	-22,406	-14.54%	✗	$684.1K
May 28, 2021	Jun 1, 2021	Xenon Pharmaceuticals Inc.	EVP, Strategy & Innovation	Sell	22.5	-10,283	-7.19%	✗	$193.8K
Jun 1, 2020	Jun 2, 2020	Xenon Pharmaceuticals Inc.	EVP, Strategy & Innovation	Sell	26.3	-1,630	-8.85%	✗	$22.3K
Sep 12, 2019	Sep 13, 2019	Xenon Pharmaceuticals Inc.	EVP, Strategy & Innovation	Sell	26.3	-1,868	-15.48%	✗	$17.5K
Mar 15, 2018	Mar 16, 2018	Xenon Pharmaceuticals Inc.	EVP Bus. & Corp. Development	Sell	27.5	-1,928	-24.65%	✗	$8.9K
May 12, 2017	May 16, 2017	Xenon Pharmaceuticals Inc.	SVP Bus. & Corp. Development	Sell	27.5	-1,345	-22.13%	✗	$5.6K
Dec 16, 2015	Dec 21, 2015	Xenon Pharmaceuticals Inc.	SVP Bus. & Corp. Development	Sell	27.5	-229	-5.39%	✗	$1.8K
Aug 18, 2015	Aug 20, 2015	Xenon Pharmaceuticals Inc.	SVP Bus. & Corp. Development	Sell	26.3	-1,302	-16.71%	✗	$14.3K